Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance

BACKGROUND/AIM: Recent studies have suggested that periportal location of percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is considered as one of the independent risk factors for local tumor progression (LTP). However, the long-term therapeutic outcomes of percutaneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Shoujin, Lyu, Tianshi, Fan, Zeyang, Guan, Haitao, Song, Li, Tong, Xiaoqiang, Wang, Jian, Zou, Yinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725335/
https://www.ncbi.nlm.nih.gov/pubmed/34983650
http://dx.doi.org/10.1186/s40644-021-00442-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725335/
https://www.ncbi.nlm.nih.gov/pubmed/34983650
http://dx.doi.org/10.1186/s40644-021-00442-2

Ejemplares similares